Update

Search This Blog

Rival Novartis, Gilead CAR-T Therapies Win European Panel Recommendation

June 30, 2018

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

REUTERS via NYT

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

From New England to Notre-Dame, a U.S. Carpenter Tends to a French Icon

Hank Silver, a timber framer based in Massachusetts, is one of a handful of foreigners who are helping to rebuild the Paris cathedral after the devastating fire in 2019. By Aurelien Breeden | NYTimes NYT > World > Europe | Disclosure

Coaches Have to Be Salesmen, Too

David Moyes has established West Ham as a fixture in the top half of the Premier League and a regular presence in Europe. So why do so many fans want him out? By Rory Smith | NYTimes NYT > World > Europe | Disclosure

Turkey Earthquake Trial Opens Amid Anger and Tears

More than 300 people were killed when temblors toppled an upscale residential complex. Survivors hope a court will punish the men who built it. By Safak Timur and Ben Hubbard | NYTimes NYT > World > Europe | Disclosure

For Sale: A Rare Klimt Portrait, Valued at $32 Million. But of Whom?

The painting’s re-emergence after decades has come with a swirl of questions about its subject, one of three related teenage girls. By Scott Reyburn | NYTimes NYT > World > Europe | Disclosure

In an Unusual Vote, Democrats Rescue Measure to Allow Vote on Ukraine Bill

A resolution to pave the way for the foreign aid package was on track to die in committee amid Republican opposition when Democrats stepped in to save it. By Catie Edmondson | NYTimes NYT > World > Europe | Disclosure

Rival Novartis, Gilead CAR-T Therapies Win European Panel Recommendation

Comments

Post a Comment